Sapiens International Corporation NV

SPNS · NASDAQ

Price unavailable right now.

No price history for this range.

Key indicators

SPNS profitability and balance sheet ratios

EPS $0.2534 in Sep 2025, down 22.2% on a year earlier.

EPS by quarter
PeriodEPS
Dec 2023$0.3036
Mar 2024$0.3101
Jun 2024$0.3315
Sep 2024$0.3256
Dec 2024$0.3181
Mar 2025$0.3202
Jun 2025$0.2538
Sep 2025$0.2534

Where the money went

Q1 FY21, from revenue to net income

Sapiens International Corporation NV brought in $109.6M of revenue in Q1 FY21, +21.1% on a year earlier. 9¢ of every dollar became profit.

Revenue
$109.6M
Costs, expenses and taxes
$99.8M
Net income
$9.8M
Net margin
9.0%

Income statement

Revenue and profit by reporting period

Revenue
Net income
SPNS income statement, quarterly
Line itemQ3 FY20Q4 FY20Q1 FY21
Revenue$97.6M$101.7M$109.6M
Gross profit$40.1M$41.4M$44.3M
Operating income$12.1M$10.2M$12.4M
Net income$9.3M$8.3M$9.8M
Diluted EPS$0.18$0.15$0.18

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
SPNS balance sheet, quarterly
Line itemMar 2025Jun 2025Sep 2025
Total assets$714.0M$739.6M$743.7M
Total liabilities$253.4M$241.3M$230.2M
Shareholder equity$460.6M$498.3M$513.5M
Cash and short-term investments$205.9M$74.5M$82.2M
Total debt$19.8M$19.8M$19.8M

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
SPNS cash flow, quarterly
Line itemQ3 FY20Q4 FY20Q1 FY21
Operating cash flow$16.7M$21.0M$11.8M
Investing cash flow−$15.4M−$108.8M−$2.3M
Financing cash flow$2.4M$108.7M−$20.0M
Capital expenditure−$1.0M−$0.7M−$0.8M
Free cash flow$15.7M$20.3M$10.9M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.